MX360417B - Fenilpropanoides digliceridos para el tratamiento del cancer. - Google Patents

Fenilpropanoides digliceridos para el tratamiento del cancer.

Info

Publication number
MX360417B
MX360417B MX2012004160A MX2012004160A MX360417B MX 360417 B MX360417 B MX 360417B MX 2012004160 A MX2012004160 A MX 2012004160A MX 2012004160 A MX2012004160 A MX 2012004160A MX 360417 B MX360417 B MX 360417B
Authority
MX
Mexico
Prior art keywords
cancer
alkylcarbonyloxy
alkoxy
phenylpropanoid
glycerol
Prior art date
Application number
MX2012004160A
Other languages
English (en)
Other versions
MX2012004160A (es
Inventor
Macgregor Alexander
Original Assignee
Macgregor Alexander
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Macgregor Alexander filed Critical Macgregor Alexander
Publication of MX2012004160A publication Critical patent/MX2012004160A/es
Publication of MX360417B publication Critical patent/MX360417B/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/02Antineoplastic agents specific for leukemia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/66Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
    • C07C69/73Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids
    • C07C69/732Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids of unsaturated hydroxy carboxylic acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/66Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
    • C07C69/73Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids
    • C07C69/734Ethers
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D303/00Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02Compounds containing oxirane rings
    • C07D303/12Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
    • C07D303/16Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by esterified hydroxyl radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Epoxy Compounds (AREA)

Abstract

La presente invención proporciona un método para el tratamiento de un cáncer en un sujeto, que involucra administrar al sujeto un compuesto de fórmula (II) o (II´) en donde R1, R2, R3, R4, R5, R6 y R7son independientemente H, OH, alcoxi o alquilcarboniloxi, o una sal farmacéuticamente aceptable del mismo. También se proporciona un compuesto de fórmula (II) o (II´), en donde R1 y R2 son independientemente OH, alcoxi o alquilcarboniloxi, R3 y R4 son independientemente H, OH, alcoxi o alquilcarboniloxi, R6 es H, alcoxi o alquilcarboniloxi, R5 es H, OH, o alquilcarboniloxi, R6 es H, o alcoxi, y R7 es H, o una sal farmacéuticamente aceptable del mismo. (ver fórmulas).
MX2012004160A 2009-10-09 2010-10-08 Fenilpropanoides digliceridos para el tratamiento del cancer. MX360417B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US25028709P 2009-10-09 2009-10-09
PCT/CA2010/001613 WO2011041907A1 (en) 2009-10-09 2010-10-08 Derivatives of di(phenylpropanoid) glycerol for the treatment of cancer

Publications (2)

Publication Number Publication Date
MX2012004160A MX2012004160A (es) 2012-09-07
MX360417B true MX360417B (es) 2018-10-25

Family

ID=43352967

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2012004160A MX360417B (es) 2009-10-09 2010-10-08 Fenilpropanoides digliceridos para el tratamiento del cancer.

Country Status (19)

Country Link
US (2) US9061993B2 (es)
EP (1) EP2486026B1 (es)
JP (1) JP5529280B2 (es)
CN (1) CN102264713A (es)
BR (1) BR112012008204A2 (es)
CA (1) CA2715662C (es)
CY (1) CY1123161T1 (es)
DK (1) DK2486026T3 (es)
ES (1) ES2810906T3 (es)
HR (1) HRP20201217T1 (es)
HU (1) HUE051549T2 (es)
LT (1) LT2486026T (es)
MX (1) MX360417B (es)
MY (2) MY160378A (es)
PL (1) PL2486026T3 (es)
PT (1) PT2486026T (es)
RS (1) RS60667B1 (es)
SI (1) SI2486026T1 (es)
WO (1) WO2011041907A1 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8907117B2 (en) * 2011-09-08 2014-12-09 Henry Lowe Anti-tumor and anti-inflammatory dicinnamoyl-glycerol esters and their analogues
US9402834B2 (en) 2014-10-21 2016-08-02 Ions Pharmaceutical S.À R.L. Human therapeutic agents
US9907786B2 (en) 2014-10-21 2018-03-06 Ions Pharmaceutical S.À R.L. Therapeutic compositions containing harmine and isovanillin components, and methods of use thereof
US10092550B2 (en) 2014-10-21 2018-10-09 Ions Pharmaceutical S.À R.L. Therapeutic compositions containing curcumin, harmine, and isovanillin components, and methods of use thereof

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3857873A (en) 1974-02-11 1974-12-31 Warner Lambert Co 3-hydroxy-5-(3-(substituted-amino)-2-hydroxypropoxy)-benzyl alcohols
CH648753A5 (de) * 1981-07-22 1985-04-15 Givaudan & Cie Sa Lichtschutzmittel.
CN1238333C (zh) * 2003-06-18 2006-01-25 清华大学 药物化合物菠萝酰酯及其制备方法和用途
US7713556B2 (en) 2006-12-08 2010-05-11 Henry Lowe Anti-tumor and anti-inflammatory extracts of plant biomass and their uses
EP2104659B1 (en) * 2007-01-08 2015-07-29 AndroScience Corporation Compounds with (substituted phenyl)-propenal moiety, their derivatives, biological activity, and uses thereof
TWI383251B (zh) * 2008-01-16 2013-01-21 Eternal Chemical Co Ltd 感光型聚醯亞胺
KR101074149B1 (ko) * 2009-04-15 2011-10-17 한밭대학교 산학협력단 신규 폴리페놀/폴리페놀 컨쥬게이트 화합물 및 그의 용도
US8907117B2 (en) * 2011-09-08 2014-12-09 Henry Lowe Anti-tumor and anti-inflammatory dicinnamoyl-glycerol esters and their analogues

Also Published As

Publication number Publication date
PT2486026T (pt) 2020-08-21
JP2013507327A (ja) 2013-03-04
US20110086912A1 (en) 2011-04-14
US20150246014A1 (en) 2015-09-03
CY1123161T1 (el) 2021-10-29
WO2011041907A1 (en) 2011-04-14
MX2012004160A (es) 2012-09-07
MY160378A (en) 2017-03-15
US10052301B2 (en) 2018-08-21
ES2810906T3 (es) 2021-03-09
PL2486026T3 (pl) 2020-11-02
HRP20201217T1 (hr) 2020-12-11
CN102264713A (zh) 2011-11-30
US9061993B2 (en) 2015-06-23
SI2486026T1 (sl) 2020-10-30
LT2486026T (lt) 2020-09-10
EP2486026A4 (en) 2015-07-01
RS60667B1 (sr) 2020-09-30
DK2486026T3 (da) 2020-08-17
EP2486026A1 (en) 2012-08-15
CA2715662C (en) 2013-05-07
BR112012008204A2 (pt) 2017-07-18
EP2486026B1 (en) 2020-06-24
MY187188A (en) 2021-09-09
JP5529280B2 (ja) 2014-06-25
HUE051549T2 (hu) 2021-10-28
CA2715662A1 (en) 2010-12-14

Similar Documents

Publication Publication Date Title
JO2848B1 (en) Organic compounds
EA201270570A1 (ru) Комбинированная терапия раковых заболеваний с помощью соединений-ингибиторов hsp90
MY146111A (en) Acylaminopyrazoles as fgfr inhibitors
MA31358B1 (fr) Méthodes de traitement du cancer à l'aide d'inhibiteurs de pi3k alpha à base de pyridopyrimidinone
EA200970935A1 (ru) Способы лечения с применением хинаксолиновых ингибиторов pi3k-альфа
NZ619259A (en) Inhibitors of influenza viruses replication
TW200806299A (en) Treatment of pain
MX2011011083A (es) Compuestos heterociclicos como inhibidores de mek.
MX2011009796A (es) Inhibidores de la cinasa pi3.
EA201300860A1 (ru) Кристаллические трипептидные ингибиторы эпоксикетон-протеазы
MX2008010931A (es) Quinolonas utiles como inhibidores de sintasa de oxido nitrico inducibles.
HK1138262A1 (en) Novel phosphodiesterase inhibitors
TW200639159A (en) Treatment of pain
MX2013010770A (es) Tratamiento de tumores solidos.
CY1123161T1 (el) Παραγωγα δι(φαινυλοπροπανοειδους) γλυκερολης για τη θεραπεια του καρκινου
MX2009012613A (es) Tiazoles substituidos por heteroarilo y su uso como agentes antivirales.
MX2011009709A (es) Compuestos para el tratamiento de la inflamacion y del dolor.
UA96969C2 (en) Acylaminopyrazoles as fgfr inhibitors
WO2010121675A3 (en) Thiazolyl-benzimidazoles
MX2011012068A (es) Nucleosidos 2'-fluoro arabino y su utilizaicon.
EA201270347A1 (ru) Производные апогоссиполона в качестве противоопухолевых агентов
UA98639C2 (en) Phosphodiesterase inhibitors
EA200970615A1 (ru) Соединения имидазолидинониламинопиримидина для лечения рака
WO2011133826A3 (en) Method for treating pancreatic cancer
TW200730177A (en) 4 anilino-3-quinolinecarbonitriles for the treatment of cancer

Legal Events

Date Code Title Description
FG Grant or registration